The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of zandelisib administered by intermittent dosing (ID) in patients with relapsed or refractory (R/R) follicular lymphoma (FL): Primary analysis of the global phase 2 study TIDAL.
Andrew David Zelenetz
Honoraria - Curio Science; NCCN; OncLive/MJH Life Sciences; Oncology Information Group; PER; Plexus
Consulting or Advisory Role - AstraZeneca; BeiGene; Celgene; Coherus Biosciences; Curis; Dava Oncology; Debiopharm Group; Genentech/Roche; Gilead Sciences; Juno/Celgene/Bristol-Myers Squibb; Karyopharm Therapeutics; Kite, a Gilead company; MEI Pharma; MorphoSys; Ono Pharmaceutical; Quant Health; Sandoz; Verastem
Research Funding - BeiGene; Genentech/Roche; Gilead Sciences; MEI Pharma
Wojciech Jurczak
Consulting or Advisory Role - AstraZeneca; Debiopharm Group; Epizyme; Janssen-Cilag; Roche
Research Funding - Acerta Pharma; Bayer; BeiGene; Debiopharm Group; Epizyme; Incyte; Janssen-Cilag; MEI Pharma; Morphosys; Roche; Sandoz-Novartis; Takeda; TG Therapeutics; TG Therapeutics
Vincent Ribrag
Honoraria - Abbvie; AZD; Gilead Sciences; Infinity Pharmaceuticals; NanoString Technologies; Novartis; roche
Consulting or Advisory Role - Bristol-Myers Squibb; Gilead Sciences; Immune Design; Incyte; Infinity Pharmaceuticals; MSD; NanoString Technologies; PharmaMar; Roche; Roche/Genentech
Research Funding - arGEN-X BVBA; argenx (Inst); Astex Pharmaceuticals (Inst); Epizyme (Inst); GlaxoSmithKline/Adaptimmune (Inst)
Expert Testimony - SERVIER
Travel, Accommodations, Expenses - azd; AZD; Bristol-Myers Squibb; Bristol-Myers Squibb; Roche
Kim Linton
Honoraria - Genmab; Roche
Consulting or Advisory Role - BeiGene; Celgene; Genmab; Karyopharm Therapeutics; Kite, a Gilead Company; Roche
Speakers' Bureau - Abbvie; Celgene
Research Funding - BeiGene (Inst); Bristol-Myers Squibb (Inst); Genmab (Inst); Johnson & Johnson (Inst); MEI Pharma (Inst); Nurix (Inst); Pharmacyclics/Janssen (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Takeda
Graham P. Collins
Honoraria - ADC Therapeutics; BeiGene; Celleron Therapeutics; Daiichi Sankyo; Gilead Sciences; Incyte; MSD Oncology; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - ADC Therapeutics; beigene; Celgene; Celleron Therapeutics; Daiichi Sankyo; Incyte; MSD; Pfizer; Roche; Takeda
Speakers' Bureau - Gilead Sciences; Novartis; Roche; Takeda
Research Funding - Amgen (Inst); BMS (Inst); Celgene (Inst); MSD Oncology (Inst)
Travel, Accommodations, Expenses - Roche; Takeda
Javier López-Jiménez
Consulting or Advisory Role - Abbvie; Gilead Sciences; Janssen Oncology; Roche/Genentech
Speakers' Bureau - Abbvie; Pfizer; Roche/Genentech
Research Funding - Abbvie; Roche/Genentech
Travel, Accommodations, Expenses - Abbvie; Gilead Sciences; Janssen Oncology
Nishitha Reddy
Honoraria - Celgene; Morphosys
Andrea Mengarelli
Travel, Accommodations, Expenses - Takeda
Tycel Jovelle Phillips
Honoraria - Lymphoma & Myeloma Connect; Seagen
Consulting or Advisory Role - ADC Therapeutics; Bayer; Celgene; Curis; Genentech; Genmab; Gilead Sciences; Incyte; Kite/Gilead; Pharmacyclics; Seagen; TG Therapeutics
Research Funding - Abbvie; Bayer; Pharmacyclics/Janssen
Gerardo Musuraca
Honoraria - Incyte; Janssen; Roche
Consulting or Advisory Role - Incyte; Janssen Oncology; Roche
Oonagh Sheehy
Consulting or Advisory Role - Roche
Joanne Li
Employment - MEI Pharma
Stock and Other Ownership Interests - Amgen; Lilly
Weiming Xu
Employment - MEI Pharma
Stock and Other Ownership Interests - MEI Pharma
Michel Meyer Azoulay
Employment - Kyowa; Sanofi
Stock and Other Ownership Interests - Allogene Therapeutics; Epizyme; Innate Pharma
Richard Ghalie
Employment - MEI Pharma
Leadership - Viracta Therapeutics
Stock and Other Ownership Interests - MEI Pharma; Viracta Therapeutics
Travel, Accommodations, Expenses - MEI Pharma
Pier Luigi Zinzani
Consulting or Advisory Role - ADC Therapeutics; BeiGene; Bristol-Myers Squibb; Celltrion; EUSA Pharma; Gilead Sciences; Incyte; Janssen-Cilag; Kyowa Hakko Kirin; MSD; Novartis; Roche; Sandoz; Secura BIO; SERVIER; Takeda; TG Therapeutics
Speakers' Bureau - EUSA Pharma; MSD; Novartis